Literature DB >> 31131240

Microvascular changes after conbercept therapy in central retinal vein occlusion analyzed by optical coherence tomography angiography.

Yang Deng1, Qi-Wen Zhong2, Ai-Qi Zhang3, Xiao-Juan Cai4, Ming-Zhi Lu1, Shao-Chong Zhang1, Li-Shi Su1, Hui Chen1, Ying Lin1, Li-Mei Sun1, Guan-Di Chen1, Li-Ting Zhong1, Chen-Jin Jin1, Wei Chi1.   

Abstract

AIM: To investigate microvascular changes in eyes with central retinal vein occlusion (CRVO) complicated by macular edema before and after intravitreal conbercept injection and evaluate correlations between these changes and best-corrected visual acuity (BCVA) and retinal thickness.
METHODS: Twenty-eight eyes of 28 patients with macular edema caused by CRVO were included in this retrospective study. All patients received a single intravitreal conbercept injection to treat macular edema. BCVA and the results of optical coherence tomography angiography (OCTA) automatic measurements of the vessel density in the superficial (SCP) and deep retinal capillary plexus (DCP), the foveal avascular zone (FAZ) area, the FAZ perimeter (PERIM), the vessel density within a 300-µm wide ring surrounding the FAZ (FD-300), the acircularity index (AI), the choriocapillaris flow area, and retinal thickness were recorded before and at one month after treatment and compared with the results observed in age- and sex-matched healthy subjects.
RESULTS: The vessel density in the SCP and DCP, the FD-300, and the flow area of the choriocapillaris were all significantly lower in CRVO eyes than in healthy eyes, while the AI and retinal thickness were significantly higher (all P<0.05). After treatment, retinal thickness was significantly decreased, and the mean BCVA had markedly improved from 20/167 to 20/65 (P=0.0092). The flow area of the choriocapillaris was also significantly improved, which may result from the reduction of shadowing effect caused by the attenuation of macular edema. However, there were no significant changes in SCP and DCP vessel density after treatment. The flow area of the choriocapillaris at baseline was negatively correlated with retinal thickness.
CONCLUSION: OCTA enables the non-invasive, layer-specific and quantitative assessment of microvascular changes both before and after treatment, and can therefore be used as a valuable imaging tool for the evaluation of the follow-up in CRVO patients.

Entities:  

Keywords:  central retinal vein occlusion; conbercept; flow area; foveal avascular zone; macular edema; optical coherence tomography angiography; vessel density

Year:  2019        PMID: 31131240      PMCID: PMC6520287          DOI: 10.18240/ijo.2019.05.16

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  8 in total

1.  Comment on "Microvascular changes after conbercept therapy in central retinal vein occlusion analyzed by optical coherence tomography angiography".

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Int J Ophthalmol       Date:  2020-05-18       Impact factor: 1.779

2.  Efficacy of conbercept after switching from bevacizumab/ranibizumab in eyes of macular edema secondary to central retinal vein occlusion.

Authors:  Tong Zhao; You Chen; Hong-Song Zhang; Yi Chen; Zhi-Jun Wang
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

3.  Efficacy of intravitreal conbercept injection on short- and long-term macular edema in branch retinal vein occlusion.

Authors:  Jing-Yi Bai; Wen-Ying Wang; Zhi-Zhi Dou; Bo-Chao Geng; Xiao-Yan Xu; Yuan-Zhang Zhu; Shan-Yao Zhao; Min Liu; Shao-You Jia; Wen-Juan Luo
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

4.  Clinical efficacy of conbercept plus micropulse laser (577 nm) treatment in macular edema secondary to non-ischemic central retinal vein occlusion.

Authors:  Li Li; Qian Ren; Zhaohui Sun; Hua Yu
Journal:  Pak J Med Sci       Date:  2022 May-Jun       Impact factor: 2.340

Review 5.  Potential Prognostic Indicators for Patients With Retinal Vein Occlusion.

Authors:  Shan Yin; Yanyan Cui; Wanzhen Jiao; Bojun Zhao
Journal:  Front Med (Lausanne)       Date:  2022-05-25

6.  Evaluation of Microvascular Structure Changes after Conbercept Treatment on Macular Edema Secondary to Retinal Vein Occlusion.

Authors:  Wenqi Song; Wanzhen Jiao; Fengjiao Li; Aihua Ma; Bojun Zhao
Journal:  Biomed Res Int       Date:  2020-06-19       Impact factor: 3.411

7.  Efficacy of intravitreal injection of conbercept on non-proliferative diabetic retinopathy: a retrospective study.

Authors:  Jing Wang; Peng-Fei Jiang; Min Liu; Ming-Rong Kou; Jia-Ying Lei; Xiao-Ting Yu; Ying Zhao; Hong Wang; Lin-Na Zhang
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

8.  Proteomic Study of Aqueous Humor and Its Application in the Treatment of Neovascular Glaucoma.

Authors:  Mengxi Yu; Feng Xie; Xiang Liu; Haidan Sun; Zhengguang Guo; Xiaoyan Liu; Wei Li; Wei Sun; Ying Wang; Chengyan He
Journal:  Front Mol Biosci       Date:  2020-10-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.